Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
Compound Norethisterone Enanthate Injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Contraception Behavior
1 trial -
Folic Acid
Hospital Authority, Hong Kong
Pregnant Women
1 trial -
GnRH-a
The First People's Hospital of Lianyungang
Clinical Pregnancy Rate
1 trial -
Hippocampal avoidance WBRT
Hospital Authority, Hong Kong
Metastatic Malignant Neoplasm to Brain
1 trial -
Hydrochloride anlotinib
Zhongnan Hospital
Uterine Cervical Neoplasms
1 trial -
Intraoperative Radiation Therapy in Malignant Cerebral Tumor
The First People's Hospital of Lianyungang
Glioblastoma
1 trial -
Intrathecal recombinant human alpha iduronidase
Ultragenyx UK Limited
Mucopolysaccharidosis I
1 trial -
JY231 Injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
B-cell Malignancies
1 trial -
LCAR-M61S cells preparation
Nanjing Legend Biotech Co.
Relapsed/Refractory Multiple Myeloma
1 trial -
Lubiprostone
Takeda
Constipation-predominant Irritable Bowel Syndrome
1 trial -
NanoDOX 1% doxycycline monohydrate Hydrogel
United Therapeutics Europe Ltd
Dehisced Surgical Wounds
1 trial -
Nutrient supplement to pregnant women (PNS)
United Therapeutics Europe Ltd
Stunting in Under-2 Children
1 trial -
Ondansetron
United Therapeutics Europe Ltd
Vomiting of Pregnancy
1 trial -
PGS 2.0
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Recurrent Pregnancy Loss
1 trial -
Percutaneous transhepatic biliary stenting with conventional linear ^125^I seeds strand
The First People's Hospital of Lianyungang
Malignant Obstructive Jaundice
1 trial -
Photo-responsive nanozyme
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Radiation Dermatitis
1 trial -
Placebo
BRIGHT MINDS BIOSCIENCES INC.
Magnetic Resonance Imaging
1 trial -
Placebo
Hospital Authority, Hong Kong
Hypertension in Pregnancy
1 trial -
Recombinant COVID-19 Vaccine (Sf9 Cell)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
COVID-19
1 trial -
S-ketamine
Nanjing Zenshine Pharmaceuticals
Opioid Use, Unspecified
1 trial -
Sucrose IronοΌsubcutaneous recombinant human erythropoietinοΌintravenous vitamin C
The First People's Hospital of Lianyungang
Anemia
1 trial -
Triferdine
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,
Pregnancy Related
1 trial -
chemotherapy
United Therapeutics Europe Ltd
Malignant Mesothelioma
1 trial -
placebo
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,
PCOS- Polycystic Ovary Syndrome
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources